High TP73 mRNA expression was significantly linked with poor survival in the whole cohort (Figure 2B), in lymph node+/ER+/PR+ breast cancers (Figure 2C), but not in lymph node+/ER-/PR- breast cancers (Figure 2D). Here, TP73 is linked to breast cancer.